Enhanced Games Holds Inaugural Competition in Las Vegas, Sparking Anti-Doping Agency Backlash

The Enhanced Games held its first formal competition in May 2026 in Las Vegas, featuring Olympic medalists competing openly with performance-enhancing drugs including steroids, testosterone, and growth hormone. The event, founded by Aron D'Souza and backed by investor Peter Thiel, offered $1 million bounties for world record performances across track, weightlifting, and swimming disciplines.

Past Olympic medalists Cody Miller, Shane Ryan, Ben Proud, and Fred Kerley participated in the competition, with almost every athlete openly using performance enhancers as part of custom drug regimens crafted by the games' medical staff. The approved substances span five categories: testosterone esters, anabolic agents, peptides and growth factors, metabolic modulators, and stimulants.

The Memorial Day Weekend event in Las Vegas followed a 12-week supervised training program in Abu Dhabi, where many athletes prepared under Enhanced Games oversight. Sprinter Fred Kerley recorded a 9.97-second 100-meter time during competition.

Regulatory Opposition Intensifies

The World Anti-Doping Agency (WADA) has condemned the Enhanced Games as dangerous and irresponsible, stating it will encourage Anti-Doping Organizations to test participating athletes before, during, and after events. The WADA Athlete Council strongly opposes the competition, though it initially chose not to make public statements in early 2024 to avoid amplifying attention toward the project.

The International Olympic Committee and WADA Athletes' Commissions have denounced the games, with the Centre for Integrity in Sport and Play (CIFP) joining their condemnation. Critics have dubbed the competition the "steroid Olympics" and "pro-doping Olympics."

Legal and Financial Framework

The Enhanced Games organization has filed an $800 million lawsuit against critics while seeking to raise $300 million in funding for its operations. Christian Angermayer is among the investors involved with the venture, which positions itself as an annual sporting event.

The competition has faced scrutiny following incidents including former MLB player Alexei Ramírez testing positive for four steroids at a World competition.

Looking at the broader trajectory here, this represents a familiar pattern in technology and regulation — the emergence of a parallel system that explicitly rejects established constraints. Having covered the early internet's circumvention of traditional publishing gatekeepers, and more recently blockchain's challenge to financial intermediaries, the Enhanced Games follows a similar playbook: create an alternative framework that makes the incumbent system's limitations the selling point rather than an obstacle to overcome.

Technical Infrastructure and Athlete Management

The Enhanced Games operates with medical oversight for drug administration, moving beyond the typical underground approach to performance enhancement that has historically plagued competitive athletics. The supervised regimen model attempts to address safety concerns while maintaining the competitive integrity that traditional anti-doping frameworks aim to preserve.

Athletes undergo comprehensive medical monitoring throughout their participation, with the 12-week Abu Dhabi training camps serving as controlled environments for both performance optimization and health tracking. The approach mirrors clinical trial methodologies more than traditional athletic preparation.

Market Positioning and Regulatory Response

The $1 million world record bounties represent a direct challenge to traditional amateur sport compensation structures, potentially creating economic incentives that could reshape athlete decision-making around career paths and competitive choices. The financial model relies on significant venture funding rather than traditional sporting federation support or broadcast revenue sharing.

WADA's testing strategy for Enhanced Games participants creates an interesting regulatory dynamic — athletes competing in an explicitly pro-PED environment still subject to anti-doping oversight in their other competitive contexts. This dual-system approach could complicate athlete eligibility for traditional competitions.

The organization's legal strategy, including the $800 million lawsuit against critics, suggests a confrontational approach to regulatory opposition rather than seeking accommodation within existing frameworks. This positions the Enhanced Games as a direct competitor to traditional sport governance rather than a complementary alternative.

Worth flagging: the Enhanced Games' emergence during a period of increased scrutiny around traditional anti-doping enforcement effectiveness creates a unique market opportunity. Recent high-profile doping cases and ongoing questions about testing consistency have created space for alternative approaches to gain traction with both athletes and audiences.

The competition's technical approach to drug administration and monitoring may provide data that traditional anti-doping research has been unable to gather due to ethical and legal constraints. Whether this information proves valuable for broader athletic performance understanding remains an open question as the organization scales beyond its inaugural event.